Your browser doesn't support javascript.
loading
Canadian Society of Clinical Chemists (CSCC) consensus guidance for testing, selection and quality management of SARS-CoV-2 point-of-care tests.
Taher, Jennifer; Randell, Edward W; Arnoldo, Saranya; Bailey, Dana; De Guire, Vincent; Kaur, Sukhbir; Knauer, Michael; Petryayeva, Eleonora; Poutanen, Susan M; Shaw, Julie L V; Uddayasankar, Uvaraj; White-Al Habeeb, Nicole; Konforte, Danijela.
Afiliación
  • Taher J; Pathology and Laboratory Medicine, Sinai Health System, Toronto, Canada; University of Toronto, Laboratory Medicine and Pathobiology, Toronto, Canada.
  • Randell EW; Department of Laboratory Medicine, Faculty of Medicine, Memorial University of Newfoundland, Newfoundland, Canada.
  • Arnoldo S; University of Toronto, Laboratory Medicine and Pathobiology, Toronto, Canada; William Osler Health System, Brampton, Canada.
  • Bailey D; Dynacare, Brampton, Canada.
  • De Guire V; Clinical Biochemistry, Maisonneuve-Rosemont Hospital, Optilab-CHUM Laboratory Network, Montreal, Canada; Biochemistry, Maisonneuve-Rosemont Hospital Research Centre, University of Montreal, Montreal, Canada.
  • Kaur S; Fraser Health Authority, Vancouver, Canada; Pathology and Laboratory Medicine, University of British Columbia, Canada.
  • Knauer M; Pathology and Laboratory Medicine, London Health Sciences Center, London, Canada; Pathology and Laboratory Medicine, University of Western Ontario, London, Canada.
  • Petryayeva E; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.
  • Poutanen SM; University of Toronto, Laboratory Medicine and Pathobiology, Toronto, Canada; University of Toronto, Medicine, Toronto, Canada; University Health Network/Sinai Health Department of Microbiology, Toronto, Canada.
  • Shaw JLV; Eastern Ontario Regional Laboratory Association, Canada; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada.
  • Uddayasankar U; Lifelabs, Toronto, Canada.
  • White-Al Habeeb N; Lifelabs, Toronto, Canada.
  • Konforte D; Lifelabs, Toronto, Canada.
Clin Biochem ; 95: 1-12, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34048776
ABSTRACT

OBJECTIVES:

A consensus guidance is provided for testing, utility and verification of SARS-CoV-2 point-of-care test (POCT) performance and implementation of a quality management program, focusing on nucleic acid and antigen targeted technologies. DESIGN AND

METHODS:

The recommendations are based on current literature and expert opinion from the members of Canadian Society of Clinical Chemists (CSCC), and are intended for use inside or outside of healthcare settings that have varied levels of expertise and experience with POCT. RESULTS AND

CONCLUSIONS:

Here we discuss sampling requirements, biosafety, SARS-CoV-2 point-of-care testing methodologies (with focus on Health Canada approved tests), test performance and limitations, test selection, testing utility, development and implementation of quality management systems, quality improvement, and medical and scientific oversight.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sociedades Científicas / Guías de Práctica Clínica como Asunto / Consenso / Pruebas en el Punto de Atención / SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline / Qualitative_research Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Biochem Año: 2021 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Sociedades Científicas / Guías de Práctica Clínica como Asunto / Consenso / Pruebas en el Punto de Atención / SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline / Qualitative_research Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Biochem Año: 2021 Tipo del documento: Article País de afiliación: Canadá